Page last updated: 2024-10-22

amifostine anhydrous and Otitis Media with Effusion

amifostine anhydrous has been researched along with Otitis Media with Effusion in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Otitis Media with Effusion: Inflammation of the middle ear with a clear pale yellow-colored transudate.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Panossian, D1
Jung, TT1
Weeks, D1
Sandefur, J1
Park, YM1
Miller, SK1
Krohn, KA1

Other Studies

1 other study available for amifostine anhydrous and Otitis Media with Effusion

ArticleYear
Effect of the radioprotector WR2721 on irradiation-induced injury to ciliated cells of eustachian tube.
    The Annals of otology, rhinology, and laryngology, 1992, Volume: 101, Issue:5

    Topics: Amifostine; Animals; Chinchilla; Cilia; Eustachian Tube; Microscopy, Electron, Scanning; Mucociliary

1992